Please ensure Javascript is enabled for purposes of website accessibility
Regeneron Pharmaceuticals Stock Quote

Regeneron Pharmaceuticals (NASDAQ: REGN)

$766.39
(0.7%)
$5.15
Price as of December 2, 2022, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Regeneron Pharmaceuticals Returns vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
REGN +20.88% +105.21% +15.44% +3,528%
S&P -11.04% +54.10% +9.02% +973%

Regeneron Pharmaceuticals Company Info

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

News & Analysis

The Fool has written over 500 articles on Regeneron Pharmaceuticals.

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
376%
 
S&P 500 Returns
119%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/03/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.